🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07505862
Recruiting Observational

Scientific Validity Assessment and Optimization of AI-Generated A3/A4 Type Questions for the Chinese Medical Licensing Examination

NCT07505862 · tracked via the Priya Life Science China tracker
Sponsor
Guangdong Provincial People's Hospital
Phase
Observational
Started
2025-10-01
Last updated
2026-04-01

Condition(s) studied

AI (Artificial Intelligence)

Study summary

This is a cross-sectional study that primarily employs quantitative analysis, supplemented by qualitative assessment. The research is conducted in two stages: Phase I consists of a model performance comparison experiment, and Phase II involves an item quality evaluation experiment. The entire study adheres to the principles of single-blinding, randomization, and standardization to ensure scientific rigor and reproducibility.

The single-blind design is implemented during the "standardized testing" phase, where the system intersperses AI-generated items with those authored by human experts. Participants remain blinded to the source of each item (AI-generated vs. human-authored) throughout the testing and scoring processes, thereby ensuring the objectivity of the evaluation results.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 1.Professional Status: Medical students currently enrolled in a Standardized Residency Training (SRT) program. 2.Educational Background: Holders of a Bachelor of Medicine degree or higher, with foundational clinical knowledge. 3.Informed Consent: Voluntarily participate in the study and provide written informed consent. 4.Technical Competency: Proficient in using digital platforms to complete assessments and scoring. Exclusion Criteria: * 1.Conflict of Interest: Individuals involved in the AI model training, prompt engineering, or the creation of the human-authored question bank for this study. 2.Inability to Complete: Presence of visual/auditory impairments or severe illness that precludes completion of the assessment within the specified time. 3.Investigator's Discretion: Any other condition that, in the opinion of the investigator, renders the participant unsuitable for the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Guangdong Provincial People's Hospital Guangzhou Guangdong Recruiting

More Guangdong Provincial People's Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07505862 on ClinicalTrials.gov ↗ ← All trials in China